BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2620662)

  • 1. Neuropeptide Y- and somatostatin-like immunoreactivities in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
    Takahashi K; Mouri T; Itoi K; Sone M; Hayashi Y; Murakami O; Ohneda M; Ohi R; Yoshinaga K
    Endocrinol Jpn; 1989 Oct; 36(5):627-33. PubMed ID: 2620662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
    Kogner P; Björk O; Theodorsson E
    Med Pediatr Oncol; 1993; 21(5):317-22. PubMed ID: 8492745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.
    Bjellerup P; Theodorsson E; Kogner P
    Eur J Cancer; 1995; 31A(4):481-5. PubMed ID: 7576950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors.
    O'Hare MM; Schwartz TW
    Cancer Res; 1989 Dec; 49(24 Pt 1):7010-4. PubMed ID: 2582442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYY-like material and its spatial relationship with NPY, CGRP and 5-HT in the lung of the Syrian golden hamster.
    Keith IM; Ekman R
    Cell Tissue Res; 1990 Dec; 262(3):543-50. PubMed ID: 2078857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts.
    Theodorsson-Norheim E; Hemsén A; Lundberg JM
    Scand J Clin Lab Invest; 1985 Jun; 45(4):355-65. PubMed ID: 3839315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neuropeptide Y-like immunoreactivity in vertebrate retina.
    Bruun A; Ehinger B; Ekman R
    Exp Eye Res; 1991 Oct; 53(4):539-43. PubMed ID: 1936189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serotonergic agents on regional concentrations of somatostatin- and neuropeptide Y-like immunoreactivities in rat brain.
    Kakigi T; Maeda K
    Brain Res; 1992 Dec; 599(1):45-50. PubMed ID: 1362920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin gene-related peptide-like immunoreactivities in pheochromocytomas.
    Mouri T; Takahashi K; Sone M; Murakami O; Ohneda M; Itoi K; Imai Y; Yoshinaga K; Sasano N
    Peptides; 1989; 10(1):201-4. PubMed ID: 2787502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man.
    Maeda K; Yasuda M; Kaneda H; Maeda S; Yamadori A
    Neuropeptides; 1994 Dec; 27(6):323-32. PubMed ID: 7898640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
    Pernow J; Lundberg JM; Kaijser L; Hjemdahl P; Theodorsson-Norheim E; Martinsson A; Pernow B
    Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma.
    Arihara Z; Takahashi K; Murakami O; Totsune K; Sone M; Satoh F; Ito S; Hayashi Y; Sasano H; Mouri T
    Peptides; 2000 Apr; 21(4):565-70. PubMed ID: 10822113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma.
    Allen JM; Yeats JC; Causon R; Brown MJ; Bloom SR
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1199-204. PubMed ID: 3571423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas.
    Adrian TE; Allen JM; Terenghi G; Bacarese-Hamilton AJ; Brown MJ; Polak JM; Bloom SR
    Lancet; 1983 Sep; 2(8349):540-2. PubMed ID: 6136694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating neuropeptide Y in plasma from uremic patients consists of multiple peptide fragments.
    Hegbrant J; Thysell H; Ekman R
    Peptides; 1995; 16(3):395-7. PubMed ID: 7651890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary.
    Byrne JM; Jones PM; Hill SF; Bennet WM; Ghatei MA; Bloom SR
    J Clin Endocrinol Metab; 1992 Oct; 75(4):983-7. PubMed ID: 1383256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry.
    Nilsson C; Westman A; Blennow K; Ekman R
    Peptides; 1998; 19(7):1137-46. PubMed ID: 9786162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
    Wu W; Xu WJ; Liu JB; Sun J; Huang YM; Lv ZB
    Math Biosci Eng; 2019 Aug; 16(6):7217-7229. PubMed ID: 31698611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma.
    Satoh F; Takahashi K; Murakami O; Totsune K; Sone M; Ohneda M; Abe K; Miura Y; Hayashi Y; Sasano H
    J Clin Endocrinol Metab; 1995 May; 80(5):1750-2. PubMed ID: 7745031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and precursor processing of neuropeptide Y in human and murine neuroblastoma and pheochromocytoma cell lines.
    O'Hare MM; Schwartz TW
    Cancer Res; 1989 Dec; 49(24 Pt 1):7015-9. PubMed ID: 2582443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.